Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹36.8b

Artemis Medicare Services Valuation

Is ARTEMISMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ARTEMISMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ARTEMISMED (₹267.8) is trading below our estimate of fair value (₹445.15)

Significantly Below Fair Value: ARTEMISMED is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ARTEMISMED?

Other financial metrics that can be useful for relative valuation.

ARTEMISMED key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.4x
Enterprise Value/EBITDA29.8x
PEG Ratio1.8x

Price to Earnings Ratio vs Peers

How does ARTEMISMED's PE Ratio compare to its peers?

The above table shows the PE ratio for ARTEMISMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average52.2x
INDRAMEDCO Indraprastha Medical
28.1xn/a₹38.8b
SHALBY Shalby
36.5x24.9%₹29.1b
HCG HealthCare Global Enterprises
113.9x39.3%₹59.9b
523323 Kovai Medical Center and Hospital
30.1xn/a₹58.6b
ARTEMISMED Artemis Medicare Services
65.8x36.5%₹36.8b

Price-To-Earnings vs Peers: ARTEMISMED is expensive based on its Price-To-Earnings Ratio (65.8x) compared to the peer average (32.3x).


Price to Earnings Ratio vs Industry

How does ARTEMISMED's PE Ratio compare vs other companies in the IN Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a26.2%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a26.2%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: ARTEMISMED is expensive based on its Price-To-Earnings Ratio (65.8x) compared to the Indian Healthcare industry average (45.3x).


Price to Earnings Ratio vs Fair Ratio

What is ARTEMISMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ARTEMISMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio65.8x
Fair PE Ratio69.7x

Price-To-Earnings vs Fair Ratio: ARTEMISMED is good value based on its Price-To-Earnings Ratio (65.8x) compared to the estimated Fair Price-To-Earnings Ratio (69.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies